| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Assessment accuracy of core needle biopsy for hormone receptors in breast cancer: a meta-analysis
|
Li, Shichao
|
|
2012
|
135 |
2 |
p. 325-334
|
artikel
|
| 2 |
Beyond radiation therapy: photodynamic therapy maintains structural integrity of irradiated healthy and metastatically involved vertebrae in a pre-clinical in vivo model
|
Lo, Victor C. K.
|
|
2012
|
135 |
2 |
p. 391-401
|
artikel
|
| 3 |
Characterisation of tumour-infiltrating macrophages: impact on response and survival in patients receiving primary chemotherapy for breast cancer
|
Heys, Steven D.
|
|
2012
|
135 |
2 |
p. 539-548
|
artikel
|
| 4 |
Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells
|
Fiskus, Warren
|
|
2012
|
135 |
2 |
p. 433-444
|
artikel
|
| 5 |
Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib
|
Daemen, Anneleen
|
|
2012
|
135 |
2 |
p. 505-517
|
artikel
|
| 6 |
Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion
|
Zhang, Tao
|
|
2012
|
135 |
2 |
p. 445-458
|
artikel
|
| 7 |
Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women’s Health Initiative observational study
|
Li, Christopher I.
|
|
2012
|
135 |
2 |
p. 611-618
|
artikel
|
| 8 |
Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer
|
Delpech, Y.
|
|
2012
|
135 |
2 |
p. 619-627
|
artikel
|
| 9 |
Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case–control study
|
Le Ray, Isabelle
|
|
2012
|
135 |
2 |
p. 603-609
|
artikel
|
| 10 |
Loss of Dicer expression is associated with breast cancer progression and recurrence
|
Khoshnaw, Sarkawt M.
|
|
2012
|
135 |
2 |
p. 403-413
|
artikel
|
| 11 |
Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer
|
Tuomela, Johanna
|
|
2012
|
135 |
2 |
p. 481-493
|
artikel
|
| 12 |
Mammographic density and breast cancer risk in White and African American Women
|
Razzaghi, Hilda
|
|
2012
|
135 |
2 |
p. 571-580
|
artikel
|
| 13 |
MMP-9 increases HER2/neu expression and alters apoptosis levels in human mammary epithelial cells (HMEC)
|
Fatunmbi, Matilda
|
|
2012
|
135 |
2 |
p. 519-530
|
artikel
|
| 14 |
Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women
|
Agboola, A. J.
|
|
2012
|
135 |
2 |
p. 555-569
|
artikel
|
| 15 |
Mortality, leukemic risk, and cardiovascular toxicity of adjuvant anthracycline and taxane chemotherapy in breast cancer: a meta-analysis
|
Petrelli, Fausto
|
|
2012
|
135 |
2 |
p. 335-346
|
artikel
|
| 16 |
Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system
|
Kwan, Marilyn L.
|
|
2012
|
135 |
2 |
p. 591-602
|
artikel
|
| 17 |
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures
|
Kabos, Peter
|
|
2012
|
135 |
2 |
p. 415-432
|
artikel
|
| 18 |
Peritumoral FOXP3+ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3+ regulatory T cell is prognostic predictor of breast cancer patients
|
Liu, Fangfang
|
|
2012
|
135 |
2 |
p. 459-467
|
artikel
|
| 19 |
Physical activity and mammographic breast density: a systematic review
|
Yaghjyan, Lusine
|
|
2012
|
135 |
2 |
p. 367-380
|
artikel
|
| 20 |
Preventing weight gain during adjuvant chemotherapy for breast cancer: a dietary intervention study
|
Villarini, A.
|
|
2012
|
135 |
2 |
p. 581-589
|
artikel
|
| 21 |
Regular screening mammography before the diagnosis of breast cancer reduces black:white breast cancer differences and modifies negative biological prognostic factors
|
Grabler, Paula
|
|
2012
|
135 |
2 |
p. 549-553
|
artikel
|
| 22 |
Risk of rash with the anti-HER2 dimerization antibody pertuzumab: a meta-analysis
|
Drucker, Aaron M.
|
|
2012
|
135 |
2 |
p. 347-354
|
artikel
|
| 23 |
Serum and glucocorticoid-regulated kinase 1 (SGK1) activation in breast cancer: requirement for mTORC1 activity associates with ER-alpha expression
|
Hall, Ben A.
|
|
2012
|
135 |
2 |
p. 469-479
|
artikel
|
| 24 |
Systemic therapy options in BRCA mutation-associated breast cancer
|
Bayraktar, Soley
|
|
2012
|
135 |
2 |
p. 355-366
|
artikel
|
| 25 |
The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer
|
Jonsdottir, Kristin
|
|
2012
|
135 |
2 |
p. 381-390
|
artikel
|
| 26 |
TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy
|
Wang, Jiayu
|
|
2012
|
135 |
2 |
p. 531-537
|
artikel
|
| 27 |
Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor
|
Kona, Fathima R.
|
|
2012
|
135 |
2 |
p. 495-503
|
artikel
|
Tijdschrift beschrijving